治療薬として抗体を設計する

Paul J Carter¹, Arvind Rajpal¹

¹Genentech, Inc., South San Francisco, CA 94080, USA.

Cell

|July 22, 2022

まとめ

抗体療法は重要な健康上の利点をもたらし急速に拡大しています新興の研究は,がんに対する抗体設計の強化,標的の投与,改善された薬の開発のための免疫性などの課題の克服に焦点を当てています.

科学分野:

バイオテクノロジーと医薬品科学
免疫学と薬物開発

背景:

抗体療法薬は,健康に重大な利益をもたらす重要な薬のクラスです.
現在の抗体療法には,さまざまな形式,標的,治療領域,投与経路が含まれています.

研究の目的:

現在の抗体療法について概要を述べる.
抗体設計の新たな方向性を強調し,がん治療の改善,標的の臓器配送 (脳,肺,消化器系),開発可能性の課題に取り組む.
抗体発見とエンジニアリングにおける機械学習の可能性を議論します

主な方法:

抗体療法に関する現在の文献のレビューと合成.
抗体設計と工学の新興傾向の分析
免疫性や投与方法などの抗体開発の課題を調査する.

主要な成果:

抗体治療薬は多様で拡大している薬種です
進歩の重要な分野には,腫瘍学のための抗体工学,特定の臓器への標的の投与,および改善された開発能力が含まれています.
機械学習は将来の抗体発見と工学に期待を寄せていますがその影響はまだ完全に理解されていません

結論:

抗体設計と投与における継続的なイノベーションは,治療効果の拡大に不可欠です.
免疫性や伝達経路の最適化といった課題に取り組むことは抗体治療の進歩の鍵です
機械学習は抗体ベースの薬の開発の将来に変革をもたらす可能性を秘めています

さらに関連する動画

07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.4K

12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.7K

関連する概念動画

01:10

Antibody Structure

61.1K

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

61.1K

01:25

Antibody Structure and Classes

3.9K

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.

3.9K

01:26

Antibody Actions

1.3K

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

1.3K

01:31

Hybridoma Technology

15.3K

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

15.3K

01:28

Structure-Activity Relationships and Drug Design

1.0K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...